Multiple Myeloma Clinical Trial

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

Summary

The purpose of this study is to continue to provide elotuzumab and/or other study drugs to participants who have participated on a prior protocol investigating elotuzumab who are not able to receive commercial drug supply.

View Eligibility Criteria

Eligibility Criteria

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

Participated in a previous elotuzumab protocol (including, but not limited to HuLuc63-1703, CA204007, CA204009, or CA204011) and is deemed by the investigator to be deriving benefit from elotuzumab and/or other study drugs as defined by the previous protocol
Receiving elotuzumab and/or other study drugs at the time of signature of informed consent
Males and Females, ages 18 and older

Exclusion Criteria:

All participants previously discontinued from an elotuzumab study for any reason
Participants not receiving clinical benefit from previous study therapy
Participants who are not medically well enough to receive study therapy as determined by the investigator

Other protocol defined inclusion/exclusion criteria could apply

Study is for people with:

Multiple Myeloma

Phase:

Phase 2

Estimated Enrollment:

67

Study ID:

NCT02719613

Recruitment Status:

Active, not recruiting

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 39 Locations for this study

See Locations Near You

Arizona Clinical Research Center, Inc
Tucson Arizona, 85715, United States
Comprehensive Blood And Cancer Center
Bakersfield California, 93309, United States
Robert A. Moss, Md Facp, Inc.
Fountain Valley California, 92708, United States
James R. Berenson, MD, Inc.
West Hollywood California, 90069, United States
Rocky Mountain Cancer Centers (Williams) - USOR
Denver Colorado, 80218, United States
Cancer Specialists of North FL
Jacksonville Florida, 32256, United States
Florida Cancer Specialists - North
Saint Petersburg Florida, 33705, United States
Emory University
Atlanta Georgia, 30322, United States
Investigative Clinical Research Of Indiana, Llc
Indianapolis Indiana, 46260, United States
Dana-Farber Cancer Institute
Boston Massachusetts, 02215, United States
Washington University School Of Medicine
Saint Louis Missouri, 63110, United States
Icahn School Of Medicine At Mount Sinai
New York New York, 10029, United States
St. Luke's University Health Network
Bethlehem Pennsylvania, 18015, United States
Texas Oncology
Dallas Texas, 75231, United States
Local Institution
Heidelberg Victoria, 3084, Australia
Local Institution
Antwerpen , 2060, Belgium
Cross Cancer Institute
Edmonton Alberta, T6G 1, Canada
Local Institution - 0011
Toronto Ontario, M5G 2, Canada
Local Institution
Halifax , B3H 2, Canada
Local Institution
Athens , 11528, Greece
Local Institution - 0036
Budapest , 1097, Hungary
Local Institution
Ancona , 60126, Italy
Local Institution
Firenze , 50134, Italy
Local Institution
Genova , 16132, Italy
Local Institution
Torino , 10126, Italy
Local Institution
Aomori-shi Aomori, 03085, Japan
Local Institution
Shibukawa-shi Gunma, 37702, Japan
Local Institution
Osaka-shi Osaka, 53000, Japan
Local Institution
Koto-ku Tokyo, 135-8, Japan
Local Institution
Chiba , 260-8, Japan
Local Institution
Kasama-shi , 30917, Japan
Local Institution
Chorzow , 41-50, Poland
Local Institution
Warszawa , 02-10, Poland
Local Institution - 0039
Warszawa , 02-77, Poland
Local Institution
Bucuresti , 03017, Romania
Local Institution
Lasi , 70048, Romania
Local Institution
Toledo , 45004, Spain
Local Institution - 0031
Cebeci Ankara , 06620, Turkey
Local Institution
London , EC1A , United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Phase:

Phase 2

Estimated Enrollment:

67

Study ID:

NCT02719613

Recruitment Status:

Active, not recruiting

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.